ANG Lifesciences India Ltd Peer Comparison
540694 · Healthcare · Current price
Peers tracked
16
ANG Lifesciences India Ltd P/E
-4.3x
Sector
Healthcare
ANG Lifesciences India Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| DIVI S LABORATORIES LTD | ₹9,375 | 69.1x | 2,48,886 |
| ZYDUS LIFESCIENCES LTD | ₹1,160 | 22.0x | 1,16,728 |
| CIPLA LTD | ₹1,394.5 | 30.3x | 1,12,634 |
| LAURUS LABS LIMITED | ₹1,954 | 92.8x | 1,05,391 |
| AUROBINDO PHARMA LTD | ₹1,734 | 25.9x | 1,00,712 |
| DR. REDDY S LABORATORIES | ₹1,185 | 26.8x | 98,904 |
| LUPIN LIMITED | ₹2,083 | 20.6x | 95,235 |
| MANKIND PHARMA LIMITED | ₹2,300.7 | 53.7x | 94,992 |
| GLENMARK PHARMACEUTICALS | ₹2,447.4 | 45.5x | 69,091 |
| ALKEM LABORATORIES LTD. | ₹5,466.5 | 28.6x | 65,362 |
| BIOCON LIMITED. | ₹385 | 175.9x | 61,985 |
| ABBOTT INDIA LIMITED | ₹27,270 | 35.2x | 57,946 |
ANG Lifesciences India Ltd versus its peers
ANG Lifesciences India Ltd operates in the Healthcare space alongside 16 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of -4.3x may be cheap in one industry and expensive in another.
More on ANG Lifesciences India Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.